The News Review:
- Data Published in Nature Medicine Highlights Ability of Peregrine …
- SMAS is a Ground Floor Opportunity in Alternative Medicine
- Natural Medicine: Balancing the benefits and risks of salt
- Breast cancer can regress without treatment, says study
- An era of medicine without the health warnings
- Doris Duke Distinguished Clinical Scientist Award
Data Published in Nature Medicine Highlights Ability of Peregrine …
MarketWatch
Bavituximab is in clinical trials for the treatment of hepatitis C virus (HCV) infection and in preclinical development for the treatment of viral hemorrhagic fevers under a contract worth up to $44. 4 million with the bioterrorism program of the U. Defense Threat Reduction Agency (DTRA).
SMAS is a Ground Floor Opportunity in Alternative Medicine
TransWorldNews (press release), GA
com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.
Natural Medicine: Balancing the benefits and risks of salt
Seattle Post Intelligencer
PT
Natural Medicine: Balancing the benefits and risks of salt
Salt has been used to add flavor and preserve foods for centuries. Many whole foods benefit from the addition of salt to bring out their full flavor. Salt also prevents the growth of some bacteria and molds, which is why it is widely used in processed foods today. Most of the salt in your diet is likely to come from packaged and fast foods. Also known as sodium chloride, salt is necessary in small amounts for good health.
Breast cancer can regress without treatment, says study
guardian.co.uk, UK
Research published in a leading medical journal will reopen the debate over breast screening. The paper, in the Archives of Internal Medicine, says screening programmes pick up cancers that are not a threat to health, leading to invasive and unnecessary treatment. But in the current state of technology, it is impossible to know which cancers would have regressed if left, and which would have gone on to kill. The incidence of breast cancer has risen in every European country with screening. Per-Henrik Zahl and colleagues from the Norwegian Institute of Public Health in Oslo studied a national screening programme introduced in the country.
Related from Bloggingrssmonster: Cancer Patients Connect and Cope by Blogging the Journey
An era of medicine without the health warnings
Irish Times, Ireland
Maybe that’s so, but it doesn’t stop some local entrepreneurial types from trying to cultivate a crop here. And in their endeavours, the use of ultraviolet lighting greatly enlarge their carbon footprint, presumably annoying our Green brethren. This is a pity because their product should be well in keeping with Green objectives inducing a hazy, happy, tree-hugging, back-to-nature euphoria. There were countless other preparations also and I can’t resist sharing this one. It is recommended especially for organic food outlets, health stores and the credulous. It is supposed to go very well with carrot juice. Extractum Lactucae (extract of lettuce) – “Take of the flowering herb of lettuce, 1,12lbs.
Doris Duke Distinguished Clinical Scientist Award
UK News, KY
”The Doris Duke Distinguished Clinical Scientist Award recognizes outstanding mid-career physician-scientists who are applying the latest scientific advances to the prevention, diagnosis, treatment and cure of disease, and enables them to support and mentor the next generation of physician-scientists conducting clinical research. The Medical Research Program at the Doris Duke Charitable Foundation supports physician-scientists who are recognized leaders in their fields and who have well-established translational research programs. "We are truly proud of Dr. Ambati’s work," said Dr. Jay Perman, dean of the UK College of Medicine and vice president for clinical affairs. "He continues to be one of our outstanding researchers, acquiring many prestigious awards for UK. But more importantly, he is making discoveries that will one day change the lives of more than 10 million people who suffer from macular degeneration.
Leave a Comment